Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05637203 · ClinicalTrials.gov registry record · Phase 3

Study About Group and Phone Follow-Up After a Crisis

A Phase 3 study of Suicide and Crisis; Emotional, sponsored by University of Rochester.

Recruiting
Registry status
Phase 3
Development phase
100
Enrollment target
2
Study locations

NCT05637203: Recruiting Phase 3 study of Suicide and Crisis; Emotional, sponsored by University of Rochester.

NCT05637203 is a Phase 3 study of Suicide and Crisis; Emotional that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 100 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05637203, a Phase 3 study of Suicide and Crisis; Emotional, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
Phase 3
Development phase
100 participants
Enrollment target
2
Study locations

Study Summary

Crisis stabilization centers (CSCs) provide a less costly and more comfortable alternative to Emergency Department care for individuals with suicidal crises. With demand for crisis alternatives growing, effective interventions that fit the unique workflows and workforce of CSCs are needed to realize their life-saving potential. To address this need, the investigators will adapt, and pilot test the effectiveness of an interpersonally enhanced recovery and follow-up intervention delivered during and after admissions acute suicidal crises.

Primary Outcome

Psychological Problem Area subscale of the Treatment Services Review. This scale consists of 5 service review items in which the person states the number of times s/he received a specified service. Outcome of interest is 0 v. \> 0. \>0 = treatment initiation

Interventions

  • BEHAVIORAL THRIVE (Toward Hope, Recovery, Interpersonal Growth, Values, and Engagement)
  • BEHAVIORAL Discharge / Safety Planning

Study Locations (2)

Arizona

  • Connections Health-Urgent Psychiatric Center - Phoenix

Tennessee

  • Mental Health Cooperative - Nashville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-04-18
Est. Completion 2026-04-30
Phase Phase 3
University of Rochester

636 total trials

What NCT05637203 shows while recruiting

NCT05637203 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which THRIVE (Toward Hope, Recovery, Interpersonal Growth, Values, and Engagement) is the first listed.

NCT05637203 reports a single indexed study location in Arizona, Tennessee.

Frequently Asked Questions

What is clinical trial NCT05637203 about?

NCT05637203 is a clinical study titled "Study About Group and Phone Follow-Up After a Crisis". Crisis stabilization centers (CSCs) provide a less costly and more comfortable alternative to Emergency Department care for individuals with suicidal crises. With demand for crisis alternatives growing, effective interventions that fit the unique workflows and workforce of CSCs are needed to realize...

What is the current status of trial NCT05637203?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2024-04-18. Estimated completion is 2026-04-30.

What conditions does trial NCT05637203 study?

This clinical trial studies the following conditions: Suicide, Crisis; Emotional.

What interventions are being tested in trial NCT05637203?

The interventions under investigation include: THRIVE (Toward Hope, Recovery, Interpersonal Growth, Values, and Engagement) (BEHAVIORAL), Discharge / Safety Planning (BEHAVIORAL).

Who is sponsoring clinical trial NCT05637203?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05637203 being conducted?

This trial has 2 study locations across Arizona, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05637203's enrollment target sits among peer trials

100 49th of 92 higher than 43 of 92 other Suicide trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05637203, the US trial registry maintained by the National Library of Medicine. NCT05637203 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.